Upadacitinib Versus IL-17 Inhibitors in Patients With Psoriatic Arthritis
NCT07386717
·
clinicaltrials.gov ↗
COMPLETED
Status
70
Enrollment
OTHER
Sponsor class
Conditions
Psoriatic Arthritis
Upadacitinib
Interleukin-17 Inhibitors
Sponsor
Peking University First Hospital